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Abstract Traditionally, muscle cell lines are cul-
tured on glass coverslips and differentiated to
investigate myoblast fusion and differentiation. Effi-
cient differentiation of myoblasts produces a dense
network of myotubes with the correct organisation for
contraction. Here we have tested the ability of
artificially generated, precisely controlled peptide
surfaces to enhance the efficiency of myoblast
differentiation. We focused on specific short peptides
from α-laminin-2 (IKVSV, VQLRNGFPYFSY and
GLLFYMARINHA) as well as residues 15–155 from
FGF1. We tested if these peptides in isolation, and/or
in combination promoted muscle differentiation in
culture, by promoting fusion and/or by improving
sarcomere organisation. The majority of these pep-
tides promoted fusion and differentiation in two
different mouse myogenic cell lines and in primary
human myoblasts. The additive effects of all four
peptides gave the best results for both mouse cell
lines tested, while primary human cell cultures
differentiated equally well on most peptide surfaces
tested. These data show that a mixture of short
biomimetic peptides can reliably promote differenti-
ation in mouse and human myoblasts.
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Introduction
Muscle cell lines, originally derived from satellite
cells are commonly used to study muscle fusion and
differentiation in tissue culture. However, levels of
fusion and differentiation can be variable depending
on the method of culture and the cell lines used. Our
challenge was to develop a more reliable method to
generate well-differentiated myotubes in culture for
this purpose. In vivo, new muscle fibres develop
within a complex thin layer of extracellular matrix
found adjacent to the plasma membrane (sar-
colemma) of muscle fibres, known as the basal
lamina. We therefore wanted to test if specific
peptides derived from key components of the basal
lamina would promote myoblast survival and differ-
entiation in culture.
A major constituent of the basal lamina of adult
skeletal muscle is Laminin 211 (also known as
merosin). Laminin is a heterotrimeric extracellular
glycoprotein, consisting of an α, a β and a γ chain
(Ehrig et al. 1990). We have previously shown that
myoblast survival and fusion into myotubes depends
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on laminin 111 (which is made up of α1, β1 and γ1
chains), and not on fibronectin or vitronectin (Clark
et al. 1997). However, the major constituent of the
basal lamina of adult skeletal muscle is not laminin
111, but laminin 211 (Sanes 2003), in which the α
chain is LAMA2 (α2). Laminin 211 has also been
reported to be important for myoblast fusion and
myotube survival (Vachon et al. 1996).
Laminin 211 plays a key role in promoting muscle
cell adhesion to the extracellular matrix and thus in
cell survival. It binds to the membrane proteins α-
dystroglycan and integrin α7. α-dystroglycan is part
of the dystrophin associated glycoprotein complex,
which is associated with the actin cytoskeleton within
the cells. Through binding to laminin 211, it thus
connects the extracellular matrix through to
cytoskeletal γ actin on the inside of the cell. α7β1
is the main integrin expressed in adult skeletal muscle
(Song et al. 1992). It exclusively binds to laminin and
is upregulated on myoblast fusion (Song et al. 1992;
Yao et al. 1996). This latter interaction promotes
several cell survival pathways (reviewed in Holmberg
and Durbeej 2013). Mutations in laminin 211 cause
muscular dystrophy in mice and humans (Tome et al.
1994; Xu et al. 1994a, b). The commonly used
muscle cell line, C2C12 (Blau et al. 1983) expresses
LAMA2 both as myoblasts and myotubes (Schuler
and Sorokin 1995), while α-dystroglycan is expressed
at lower levels in myoblasts compared to myotubes
(Kostrominova and Tanzer 1995). The presence of α-
dystroglycan in myoblasts is known to promote
myoblast adhesion (Thompson et al. 2010).
Mapping studies have shown that the α-chain of
laminin 211 (LAMA2) binds to α-dystroglycan
through its lamin G (LG) domains: LG1-3 and
LG4-5 (Talts et al. 1999). A more recent detailed
peptide mapping study showed that two peptides
within LG4, with the amino acid sequences of
VQLRNGFPYFSY and GLLFMARINHA strongly
and specifically bound α-dystroglycan, while
GLLFMARINHA also bound to heparin (Suzuki
et al. 2010). The arginine residues in both of these
peptide sequences have been identified as important
in binding to α-dystroglycan (Suzuki et al. 2010;
Wizemann et al. 2003). A synthetic peptide with the
sequence IKVAV (Ile-Lys-Val-Ala-Val), which is
found just upstream of the first LG domain from
laminin α1 is also known to be important in cell
adhesion (Tashiro et al. 1989) and to interact with
integrins (Freitas et al. 2007). The equivalent
sequence in laminin α2 is the conserved IKVSV.
A variety of other bioactive polypeptides are also
important in myogenesis. These include fibroblast
growth factors (FGFs), which are bound to proteins in
the matrix in vivo. For example, syndecan-3 and -4,
which are transmembrane heparan sulphate proteo-
glycans expressed by muscle satellite cells, regulate
FGF signaling in proliferating satellite cells. This
appears to be required for activation and proliferation
of satellite cells (Cornelison et al. 2001). While high
levels of FGF1 may inhibit myogenesis, FGF1 can
promote differentiation and exogenous FGF1 can also
prevent apoptosis in neuronal cells (Desire et al.
1998). Traditionally, growth factors such as FGF1 are
added to cell culture media, and there is increasing
evidence these growth factors remain biologically
active when immobilized onto surfaces (Feito et al.
2011). Therefore FGF1 may also help promote
myogenesis of cultured myoblasts.
Recently, a novel approach has been implemented
to display peptides known to be important for cell
adhesion by Orla Protein Technologies (Cooke et al.
2008). Peptides are engineered into the extracellular
loops of the bacterial outer membrane protein A
(OmpA). The purified protein is then applied stereo-
specifically onto a gold-coated surface via a cysteine
residue in OmpA, such that an oriented monolayer
forms, with peptides all facing upwards, accessible to
the cells in a functional conformation (Cooke et al.
2008) and at a concentration that is precisely
controlled. Gaps between the protein molecules are
filled in using thiolipids or thioalkanes, which means
that only the peptide motifs being tested are presented
to the cells. A single peptide or a mixture of different
peptides can also be used. This approach allows
precise control over concentration and make-up of
ECM peptide motifs presented to the cells.
Here, we have used this approach to test the
abilities of the three LAMA2 peptides described
above (Fig. 1; Table 1), together with an FGF1
peptide in promoting myoblast fusion and differen-
tiation. The FGF peptide consisted of amino acids
15–155 of the human FGF1, which was engineered
into the N-terminus of OmpA with a 16 amino acid
linker sequence to enhance the presentation of FGF1.
We tested if any of these peptides, alone, or in
combination, promoted fusion and/or differentiation
in culture, compared to the traditionally used glass
2160 Cytotechnology (2016) 68:2159–2169
123
coverslip, coated with gelatin. We further tested if a
non-specific peptide (c-myc) was able to support
fusion and differentiation, as a negative control for
our experiments.
Our overall aimwas to develop a reliable, consistent
method of differentiating cultured muscle cells, such
that level of fusion of myoblasts into myotubes and
myofibrillogenesis (the production of myofibrils, into
which muscle contractile proteins are precisely organ-
ised) is high. Currently, differentiation of cultured
myoblasts, particularly using standard muscle cell
lines such as the C2C12 cells, does not always give
reliable results. In particular, while the myoblasts
might fuse into multinucleated myotubes, the level of
sarcomere organisation within these myotubes can be
very low. Thismakes it challenging to use these cells to
investigate muscle differentiation, and sarcomeric
organisation. We tested three different types of
cultured muscle cells: the commonly used mouse
C2C12 cell line (Blau et al. 1983), a conditionally
immortalised mouse muscle cell clone, C1F, devel-
oped by us from the ‘immorto’ mouse (Morgan et al.
1994; Peltzer et al. 2008), and primary human skeletal
muscle cells that are commercially available.
Materials and methods
Skeletal muscle cell culture
C2C12 myoblasts [purchased from PHE (Public
Health England) culture collections: ECACC, Porton
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Fig. 1 Diagrammatic representation of laminin α2, and the
location of the peptides used. The positions of peptides B and C
are additionally shown on the structure for the G4 and G5
domains from laminin α2 (PDB:1DYK). Highlighted ‘R’ in
Orla peptides B and C may be critical for binding of α-
dystroglycan (Wizemann et al. 2003)
Table 1 Orla surface key: sequences of the peptides used in these experiments
Orla Sequence
A IKVSV (2138–2142 in LAMA1)
B VQLRNGFPYFSY (residues 2806–2817 in LAMA1)
C GLLFYMARINHA (residues 2790–2801 in LAMA1)
D FGF1 (residues 15–155)
A + D IKVSV & FGF1 (50:50)
B + D VQLRNGFPYFSY & FGF1 (50:50)
C + D GLLFYMARINHA & FGF1 (50:50)
A + B + C IKVSV & VQLRNGFPYFSY & GLLFYMARINHA (33:33:33)
A + B + C + D IKVSV & VQLRNGFPYFSY & GLLFYMARINHA & FGF1 (25:25:25:25)
c-Myc NNKLISEEDL
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Down, Salisbury, UK] were cultured in growth
media: DMEM (Dulbecco’s Minimum Essential
Medium, with high glucose, and containing Gluta-
max) (Gibco, Grand Island, NY, USA) with 20 %
FCS (Fetal Calf Serum) (GIBCO) and 1 % penicillin/
streptomycin (GIBCO) following the recommended
protocol, and differentiated in DMEM supplemented
with 2 % equine serum and 1 % penicillin/strepto-
mycin. C1F cells were isolated as a clonal line from
neonatal muscle, from the H2 Kb-tsA58 transgenic
mouse (Morgan et al. 1994) in the Peckham labora-
tory (Peltzer et al. 2008), and cultured as described
previously (Morgan et al. 1994; Peltzer et al. 2008).
Briefly, myoblasts were proliferated at 33 °C in the
presence of IFN-γ (Becton Dickinson Biosciences,
San Jose´, CA, USA) in standard growth medium
(DMEM, high glucose, Glutamax, 20 % FCS, 1 %
chick embryo extract (CEE) (CEE was prepared as
described by Dabiri et al. 1999. Briefly, 120 embryos
from 11-day-old fertilised eggs (Henry Stewart and
Co.) were extracted from the yolk sac and washed in
PBS before being decapitated and homogenised
through a 20 ml syringe. An equal volume of DMEM
(Gibco) is then added and the mixture left to sit at
room temperature for 1.5 hours, with occasional
swirling, before being aliquoted and stored at −20 °C),
1 % penicillin/streptomycin) and differentiated into
myotubes at 37 °C in the absence of IFN-γ in
differentiation medium (DMEM, 5 % FCS, 2 % CEE,
1 % penicillin/streptomycin). Primary human skeletal
muscle cells were purchased from Public Health
England [PHE: HSkMC (150-05F)], and cultured and
differentiated as recommended in growth and differ-
entiation medium additionally purchased from PHE.
Cells were allowed to differentiate for 5 days.
Orla surfaces
Orla (Orla Peptides were provided by Orla Protein
Technologies Ltd., Bioscience Centre, Newcastle
Upon Tyne, UK) surfaces were produced using the
previously described method (Cooke et al. 2008).
Briefly, cleaned glass coverslips, coated with a 25 nm
layer of gold were cleaned and used to attach the Orla
peptides via a cystein residue. The coverslips were
coated in protein using 3 9 1 h incubation steps,
using 250 μL protein solution for each incubation,
with the Orla peptide at a concentration of 0.1 μM.
This results in a concentration of the Orla peptides at
approximately 150 ng/cm2. Where surfaces were
coated with more than one protein, the proteins were
mixed at equal molarity and applied to surface as a
mixed protein solution. For example, when a mixture
of 4 peptides was used, they were mixed in equal
parts (25 % for each peptide).
A variety of Orla surfaces (Table 1) were used
with either contained single peptides (for each
peptide tested) or a mixture of peptides. 3 LAMA2,
and an FGF1 peptide were tested (Table 1). In
addition, control c-myc peptides were tested for
C2C12 and C1F cells. Gelatin (0.1 % w/v) coated
glass (Porcine skin gelatin (Sigma) at 0.1 % concen-
tration in water, filter sterilized; a small drop was
added to the coverslip and left for 1–2 mins, then
aspirated off and allowed to air dry in the tissue
culture hood, before adding the cells), which is
commonly used to coat glass for cultured muscle cell
differentiation, was used as a additional control for all
cell lines tested. The Orla surfaces were sterilised
with a 15 min incubation in 70 % ethanol before cell
seeding. The Orla peptides are covalently linked to
the glass surfaces, via silane thiol chemistry, making
removal of the peptides by the cells during cell
culture unlikely.
In total, we performed 3 experiments for C2C12
cells. To compare these results with those for other
cell lines, we additionally performed 2 separate
experiments for C1F cells. We only performed 1
experiment for primary HuSK cells as these cells can
only be passaged for a limited amount of time. All of
the surfaces listed (Table 1) were tested in each
experiment as well as controls using gelatin coated
glass coverslips only.
Proliferation assays
Proliferation assays were performed for a subset of
the Orla surfaces, using C2C12 and C1F myoblasts
only. C2C12 and C1F myoblasts were plated onto the
Orla surfaces at a density of 1 9 104 per mL. Images
were taken using a CytoMate camera (Cytomate
Technologies, B.V., Eindhoven, The Netherlands) in
which the cell culture dishes are placed on the
cytomate, and images taken of the cells as they grow
while in the cell culture incubator, minimising any
disturbances to the cells. A 109 objective was used.
Images were taken 2 h after plating (t = 0 h for
analysis) and every 24 h until cells reached
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confluency ([90 %). The cell coverage function in
the Cytomate software was used to measure cell
proliferation. 3 images were taken at each time point
and the experiment was performed in triplicate.
Immunostaining
To perform immunostaining, first the cells were fixed
with freshly made 2 % paraformaldehyde (PFA) in
phosphate buffered saline (PBS) for 15–20 min. Cells
were then permeabilised with 0.5 % Triton-X in PBS
and incubated with murine primary antibodies that
recognise all isoforms of skeletal myosin (A4.1025).
The antibodies were obtained from hybridoma cul-
tures in the Peckham laboratory, using hybridomas
originally derived by Helen Blau (Maggs et al. 2000).
The secondary antibody used was anti-mouse Alexa
Fluor 488 (Invitrogen Molecular Probes, Eugene, OR,
USA) and DAPI (Molecular Probes) was used for
nuclear visualisation.
Images of fixed and stained cells were obtained
using a Deltavision deconvolution system at either
low magnification (using the 209 objective) to
analyse fusion, or at high magnification (using the
1009 objective) to analyse sarcomere organisation.
Images taken at the higher magnification involved
taking a Z-stack of images, followed by a deconvo-
lution process, and then the entire Z-stack was
combined into a final projection image prior to
analysis. Additional tiled images were obtained using
the Zeiss LSM 880 microscope (Oberkochen, Ger-
many), using the 409 N.A. 1.4 oil objective to image
a large field of view at high magnification to further
compare fusion in the different cell lines.
Analysis of fusion and sarcomere organisation
Low magnification images of differentiated cells (as
described above), that were fixed and stained for
skeletal myosin and nuclei (using DAPI) were used to
calculate the fusion index for the differentiated cells
after 5 days of differentiation. The total number of
nuclei in each field of view was counted together with
the total number of nuclei within myotubes (which
were stained positively for myosin heavy chain). This
analysiswas repeated for aminimumof 5 fields of view
per surface, per experiment. The fusion index was then
calculated as the proportion of nuclei within myotubes
as a function of the total number of nuclei. Thismethod
of estimating fusion is a commonly used approach in
the muscle field. Fusion indices were calculated
separately by 3 researchers and the data combined.
Sarcomeric organisation of the high magnification
projection images was analysed using ImageJ. Lines,
with a fixed length, were drawn randomly within each
image, and the line intensity profile along the lines was
measured. A minimum of 3 Z-stack maximum projec-
tion images were used for each ORLA surface, and 4
lines were drawn per image; resulting in a minimum of
12 graphs per surface, per experiment. Line profiles for
myotubes in which sarcomeric organisation is highly
organised generated graphs with defined peaks and
troughs, while line profiles for myotubes in which
sarcomeric organisation was low, lacked regular
features (examples are shown in Fig. 5b). The number
of peaks per graph with the correct periodicity for
sarcomeric banding (around 2 μm) were measured and
averaged per surface. As with fusion indices, these
measurements were performed by three separate
researchers, and the data combined.
Results and discussion
Fusion and proliferation
The ability of the cultured myoblasts to fuse strongly
depended on cell type (Fig. 2). C1F myoblasts showed
the greatest ability to fuse, while human skeletal
myoblasts (HuSK) and C2C12 myoblasts were less
efficient at fusing. The ability of the myoblasts to fuse
is demonstrated by confocal images of the myotubes
formed following fusion of the myoblasts on the
different surfaces, after 5 days under differentiation
conditions (Fig. 2). These cells have been fixed and
stained for skeletal muscle myosin, which is only
expressed once the cells have differentiated. For the
mouse myoblast line C1F, the surfaces are almost
completely covered by long, skeletal myosin positive,
myotubes. For the mouse myoblast line C2C12, while
myotubes are present, there are fewer of them,
although all the cells were plated at the same density
in each experiment. HuSK myoblasts were similar to
C2C12 myoblasts in terms of fusion.
Quantification of fusion, which measures the
numbers of nuclei present in a field of view, and
how many of these nuclei are present in the
myotubes, showed that C1F cells had the highest
Cytotechnology (2016) 68:2159–2169 2163
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Fig. 2 Effects of different
surfaces on fusion for
mouse and human cells.
The images shown are of
5 day myotubes, fixed and
stained for skeletal myosin,
which is only expressed in
differentiated cells, the
majority of which are
multinucleated myotubes.
Results for the two mouse
muscle cell lines, with C1F
are shown in a and C2C12
in b and these results
include a further test on an
Orla surface in which the
peptide presented is c-Myc,
which is not expected to
promote myoblast fusion
and differentiation. For
comparison, results for
primary human skeletal
muscle cells (HuSK) are
shown in c. These cells
were not tested for
differentiation on the c-Myc
surface. Scale bar is
200 μm
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fusion index (Fig. 3), in that the majority of the nuclei
were in multinucleated myotubes (~60–80 % on most
surfaces). The fusion index obtained for human
skeletal muscle cells (HuSK) and C2C12 cells was
similar, and lower than that obtained for C1F cells
at ~40 % on average (Fig. 3).
Tests of the single LAMA2 peptides for all three
cell types, showed that Orla C (with the sequence
GLLFYMARINHA, Table 1) was the best in pro-
moting fusion for all three cell types, as quantified by
the fusion indices obtained. While the differences in
the fusion indices for the different single peptides
were generally small, fusion on OrlaC was signifi-
cantly higher for C2C12 myoblasts than fusion on
gelatin, which is commonly used as a substrate for
fusion and differentiation of myoblasts. In contrast,
fusion of C1F and C2C12 cells on the c-myc Orla
peptide, which is not expected to support fusion, was
significantly reduced compared to fusion on gelatin,
and to fusion on Orla C, for C2C12 and C1F cells.
Thus, the c-myc peptide is unable to support fusion,
while the LAMA2 peptides promote fusion for all the
cell lines tested.
Tests for the mixture of pepides showed that an
equimolar mixture of all three LAMA2 peptides,
together with FGF1 (Figs. 2, 3) increased fusion
significantly for both C2C12 and C1F cells, com-
pared to differentiation on a gelatin only surface, or
on c-myc peptide surfaces. In contrast, mixtures of
FGF1 and one of the LAMA2 peptides (A&D, B&D
or C&D) did not improve fusion compared to the
single LAMA2 peptides alone. In addition, the
mixture of all three LAMA2 peptides (A&B&C)
was not markedly different from the results obtained
for each peptide in isolation. A similar trend was
observed for HuSK cells, although this increase in
fusion was not significant. These results suggest that
each peptide is reasonably good in promoting fusion
in isolation, and they do not work synergistically,
unless all 3 LAMA2 peptides and the FGF1 peptide is
present. This effect was most marked for the two
mouse muscle cell lines, C1F and C2C12.
To test if this effect on fusion was due to
differences in proliferation of the cells prior to
fusion, we analysed rates of proliferation on three
of the surfaces: FGF1 alone, the mixture of all three
LAMA2 peptides together with FGF1 (A&B&C&D),
and the c-myc peptide (Fig. 4). None of these
surfaces affected proliferation of the C2C12
myoblasts, confirming that any differences in fusion
observed were not due to changes in proliferation.
For the C1F myoblasts, FGF1 did increase
C1F
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Fig. 3 Analysis of fusion for C1F, C2C12 and HuSk cells.
Data show the mean ± SD for three experiments (C2C12 in b),
and two experiments (C1F in a). For HuSk (c), the data shown
are the mean ± SD for the individual measurements of fusion
from 5 different regions, from a single experiment. *Significant
difference from cells cultured on gelatin (p\ 0.05). Almost all
the surfaces showed a significant increase in fusion compared
to fusion on c-myc Orla peptides for C2C12 and C1F (HuSK
was not tested for c-myc), apart from A&D and A (for C1F)
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proliferation significantly above that observed for the
mixture of all 4 peptides (A&B&C&D), and c-myc.
However, the rate of proliferation for C1F cells on the
c-myc peptide, and the mixture of all 4 peptides was
not significantly different. As fusion on the mixture
of all 4 peptides was significantly higher than in the
other two conditions, we can conclude any effects on
proliferation are not the underlying cause of improve-
ments in fusion.
Sarcomere organisation
Sarcomere organisation also varied markedly between
the three different cell types used (Fig. 5). Sarcomere
organisation was best for the differentiated HuSK
myotubes, intermediate for C1F myotubes, and worst
for C2C12 myotubes (Fig. 5c). This was quantified by
measuring the number of peaks along a line of fixed
length across multiple myotubes in multiple fields (see
methods). The higher the average number of peaks, the
more likely that the majority of myotubes contain a
more highly striated organisation of skeletal myosin,
and thus good sarcomere organisation. These results
show that sarcomere organisation does not necessarily
correlate with the ability of the cells to fuse, as HuSK
myoblasts had a similar fusion index to C2C12 cells,
but showed better sarcomere organisation, whereas
C1F cells fused well, but had intermediate levels of
sarcomere organisation.
Tests of the Orla peptides showed that, as with
fusion, the best sarcomere organisation for C1F cells
was obtained for the mixture of all 4 peptides (Fig. 5)
and the improvement in sarcomere organisation was
significantly increased compared to that obtained on
gelatin. This suggests that surfaces that promote
fusion for individual cell types, can also support
better levels of sarcomere organisation, as C1F cells
fused best on the mixture of all 4 peptides, and
sarcomere organisation was also best on that surface.
However, for single peptides, Orla B (GLLFYMAR-
INHA), rather than C showed the best results for
sarcomere organisation. Adding in FGF1 to single
LAMA2 peptides slightly improved results for
IKVSV (A&D), but not the other two LAMA2
peptides. Generally, sarcomere organisation was
improved on all of the Orla surfaces, compared to
gelatin alone. C-myc peptides were very poor at
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Fig. 4 Analysis of cell proliferation for C1F and C2C12 cells
on selected surfaces. The rate of increase of cell coverage on
FGF-1, the mixture of all 4 peptides (A&B&C&D: FGF-1, and
the three laminin peptides), as well as c-myc was measured
over 96 h. Experiments were conducted in triplicate. Statistical
differences are shown as *p \ 0.05; **p \ 0.001
cFig. 5 Differentiation of mouse and human myogenic cell
lines on different surfaces. a Images of myotubes for each type
of surface, for C1F (mouse), C2C12 (mouse) and HuSK
(human) cells. (C-myc was not tested for HuSK cells).
b Analysis of sarcomere organisation (see “Materials and
methods”). Sarcomeres can range from highly organised
(multiple peaks/highly banded) to medium to low (no banding).
The intensity profiles along the red lines shown in these images
were used to generate the intensity profiles shown below.
c Analysis of sarcomere organisation for C2C12 (mouse cell
line), C1F (mouse cell line;) and human skeletal muscle cells.
Values shown are the mean ± SD values from two experiments
for C1F and C2C12, and 1 experiment for human skeletal
muscle cells (showing the mean ± SD, for n = 15–18
observations). *Significant difference from cells cultured on
gelatin (p\ 0.05). Values for results on nc-myc are not shown
in this analysis, as cells with a sarcomeric arrangement were
only rarely found (see a). (Color figure online)
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promoting sarcomere organisation, and almost no
myotubes were observed with recognisable banded
structures (Fig. 5a).
For C2C12 cells, the best sarcomere organisation
was again obtained for the mixture of all 4 peptides
(Fig. 5), again linking an improvement in fusion with
that of differentiation for an individual cell type. The
improvement in sarcomere organisation was signifi-
cantly increased compared to gelatin. The best single
peptide was IKVSV (A). Adding in FGF1 to the
single LAMA2 peptides did not improve sarcomere
organisation beyond that of the LAMA2 peptides
alone. In general, all the peptides improved sarcom-
ere organisation compared to gelatin alone. As with
CIF cells, C-myc peptides were very poor at
promoting sarcomere organisation, and almost no
myotubes were observed with recognisable banded
structures (Fig. 5a).
HuSK cells appeared to have well organised
sarcomeres on most surfaces, with the exception of
Orla C. As their sarcomeric organisation is already the
highest compared to the other cell lines, it is possible
that Orla peptides have less effect on their sarcomere
organisation compared to C1F and C2C12 cells.
These data show that the extent to which each of
the different types of cultured cells (C1F, C2C12 and
HuSk) can fuse and differentiate is largely deter-
mined by the inherent properties of these cells.
However, use of the Orla surfaces is able to improve
fusion and differentiation above that of using gelatin,
and is significantly better than using an unrelated
peptide such as c-myc, which is not expected to
promote fusion. Moreover, using the combination of
all 3 LAMA2 peptides and FGF1 significantly
improved fusion and differentiation for the two
mouse myogenic cell lines (C1F and C2C12), and
was the best surface for the human myogenic (HuSK)
cells. It is also noticeable that there is less variation in
the fusion index and sarcomere organisation on this
particular surface compared to the other surfaces
used. For fusion, GLLFYMARINHA appears to be
the most effective of the three LAMA2 peptides we
tested, when used as a single peptide.
Overall, the combination of all three of the
LAMA2 peptides with FGF1 was best for both fusion
and differentiation for the two mouse myogenic cell
lines (C2C12 and C1F). This combination was also
better for HuSK cells. It is interesting that fusion and
differentiation can be improved by adding FGF1 to
the mixture of all three LAMA2 peptides, although
the combination of FGF1 with any of the LAMA2
peptides in isolation is less effective. Exogenous
FGF1 might be expected to promote proliferation
rather than differentiation (Uruno et al. 1999).
However, using the mixture of all 4 peptides did
not show significant effects on proliferation for
C2C12 cells, and only a small increase for C1F cells,
although this was significant. Although the FGF1 is
covalently coupled to the glass surface via the Orla
peptide, other studies have shown that these growth
factors remain biologically active when immobilized
onto surfaces (Feito et al. 2011). Thus, we suspect
that when used in combination with the three
LAMA2 peptides, FGF1 is able to promote myotube
survival, and the slightly lower relative concentration
of FGF1 in the mixture of all 4 peptides, where FGF
is at 25 % of the concentration compared to a surface
that only contains the FGF1 peptide, is better
optimised for promotion of proliferation and myo-
blast survival prior to and during differentiation, than
the higher levels of FGF1 present in the mixtures
with a single peptide. Alternatively, there is a
synergistic effect between FGF1 and the 3 LAMA2
peptides that promotes myotube differentiation.
In conclusion, using the three LAMA2 peptides in
combination with FGF1 promotes fusion and differ-
entiation, and gives more consistent results for each
of the cell lines tested here, and should be useful for
studies that require well-differentiated cultured mus-
cle cells in the future.
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